Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia
If you're looking for acute detoxification perhaps after a period of poor diet, stress, or environmental exposure we might recommend 2-3 treatments per week for 2-3 weeks to jump-start your body's cleansing processes
AOD-9604 exhibits strong lipolytic activity The primary task of AOD-9604 is to stimulate lipolysisthe process of breaking down and burning fatand to inhibit lipogenesisthe process of creating new fat cells
A significant difference was found between the annualized rate of gray matter (GM) atrophy for the low-dose versus high-dose groups of patients ( P = 0.04)
No serious adverse events, hospitalization, organ damage, death, have been documented in any published BPC-157 research
Per-cycle dose decisions belong with a licensed physician